There was an interview with Paul from a number of years ago. During the interview he said something along the lines of.... A really well run Biotech company can get an ordinary drug to market, and a poorly run Biotech will struggle to get a blockbuster drug to market....Which one is Imugene?
Also, he said that the game plan is to see a drug at Phase 2.
Ann: Change of Director's Interest Notice - PH, page-149
-
- There are more pages in this discussion • 77 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.4¢ |
Change
-0.003(5.26%) |
Mkt cap ! $395.2M | |||
| Open | High | Low | Value | Volume |
| 5.5¢ | 5.7¢ | 5.4¢ | $1.444M | 26.24M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 24 | 3824179 | 5.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.5¢ | 172983 | 1 |
View Market Depth
| Last trade - 16.10pm 27/06/2024 (20 minute delay) ? |
| IMU (ASX) Chart |